153 results on '"T. Sazuka"'
Search Results
52. A clinical investigation of recurrence and lost follow-up after renal cell carcinoma surgery: a single-center, long-term, large cohort, retrospective study.
- Author
-
Arai T, Sazuka T, Sato H, Kato M, Kamada S, Katsura S, Seito A, Miyamoto S, Wakai K, Takeuchi N, Imamura Y, Sakamoto S, Komiya A, and Ichikawa T
- Subjects
- Follow-Up Studies, Humans, Neoplasm Recurrence, Local surgery, Nephrectomy methods, Prognosis, Retrospective Studies, Carcinoma, Renal Cell pathology, Kidney Neoplasms pathology
- Abstract
Background: Late recurrence of renal cell carcinoma (RCC) is observed in some postoperative patients. In addition, some of these patients are lost to long-term postoperative follow-up. We reviewed the treatment results and prognosis of postoperative patients with RCC at Chiba University Hospital, with the aim of clarifying the proportion and background of patients lost to follow-up., Methods: This retrospective study included 1176 RCC patients who underwent radical or/and partial nephrectomy. Overall survival (OS), cancer-specific survival (CSS), recurrence-free survival (RFS), and lost follow-up free survival (LFFS) were evaluated and the risk factors for LFFS identified., Results: The median RFS for stage II and II cases was 188.3 and 104.0 months, respectively. Even in stage I, recurrence was observed in about 20% of patients 20 years after surgery. The Kaplan-Meier curve for LFFS showed a linear descent over time, with 50% of patients lost to follow-up within 25 years. Older age (≥ 62 years), histological type (clear cell RCC), and no recurrence were significant risk factors for lost follow-up., Conclusions: Long-term follow-up is necessary after RCC surgery because late recurrence cases are not uncommon. We believe that lifelong follow-up with imaging studies is recommended for postoperative RCC patients. Early detection of recurrence in postoperative patients is a very important issue, and it may be worthwhile for improving the prognosis of postoperative patients to focus on patients lost to follow-up who may have been overlooked., (© 2022. The Author(s) under exclusive licence to Japan Society of Clinical Oncology.)
- Published
- 2022
- Full Text
- View/download PDF
53. Editorial Comment from Dr Sazuka to Prognostication in Japanese patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomy.
- Author
-
Sazuka T
- Subjects
- Administration, Intravesical, Cystectomy, Humans, Japan epidemiology, BCG Vaccine therapeutic use, Urinary Bladder Neoplasms drug therapy, Urinary Bladder Neoplasms surgery
- Published
- 2022
- Full Text
- View/download PDF
54. [A Case of Noninvasive Ductal Carcinoma Arising in Benign Phyllodes Tumor].
- Author
-
Sazuka T, Kimura M, Iwata M, Muto Y, Arasawa T, Kuboshima M, Tasaki K, Sugamoto Y, Denda Y, Asai Y, Fukunaga T, and Matsubara H
- Subjects
- Aged, Female, Humans, Mastectomy, Mastectomy, Segmental, Breast Neoplasms surgery, Carcinoma, Ductal, Breast surgery, Phyllodes Tumor surgery
- Abstract
A 70-year-old woman underwent a partial mastectomy with preoperative diagnosis of phyllodes tumor. Histopathological examination of the resected specimen revealed noninvasive ductal carcinoma of up to 20 mm in the phyllodes tumor. We note the possibility of a situation in which a phyllodes tumor is accompanied by cancer, and detailed pathological examination is necessary.
- Published
- 2022
55. Enhanced production of γ-amino acid 3-amino-4-hydroxybenzoic acid by recombinant Corynebacterium glutamicum under oxygen limitation.
- Author
-
Kawaguchi H, Hasunuma T, Ohnishi Y, Sazuka T, Kondo A, and Ogino C
- Subjects
- Amino Acids metabolism, Amino Acids, Acidic genetics, Amino Acids, Acidic metabolism, Bacterial Proteins genetics, Batch Cell Culture Techniques, Corynebacterium glutamicum genetics, Fermentation, Glucose metabolism, L-Lactate Dehydrogenase genetics, Metabolic Networks and Pathways, Metabolome, Sequence Deletion, Aminobenzoates metabolism, Corynebacterium glutamicum metabolism, Hydroxybenzoates metabolism, Metabolic Engineering methods, Oxygen metabolism
- Abstract
Background: Bio-based aromatic compounds are of great interest to the industry, as commercial production of aromatic compounds depends exclusively on the unsustainable use of fossil resources or extraction from plant resources. γ-amino acid 3-amino-4-hydroxybenzoic acid (3,4-AHBA) serves as a precursor for thermostable bioplastics., Results: Under aerobic conditions, a recombinant Corynebacterium glutamicum strain KT01 expressing griH and griI genes derived from Streptomyces griseus produced 3,4-AHBA with large amounts of amino acids as by-products. The specific productivity of 3,4-AHBA increased with decreasing levels of dissolved oxygen (DO) and was eightfold higher under oxygen limitation (DO = 0 ppm) than under aerobic conditions (DO ≥ 2.6 ppm). Metabolic profiles during 3,4-AHBA production were compared at three different DO levels (0, 2.6, and 5.3 ppm) using the DO-stat method. Results of the metabolome analysis revealed metabolic shifts in both the central metabolic pathway and amino acid metabolism at a DO of < 33% saturated oxygen. Based on this metabolome analysis, metabolic pathways were rationally designed for oxygen limitation. An ldh deletion mutant, with the loss of lactate dehydrogenase, exhibited 3.7-fold higher specific productivity of 3,4-AHBA at DO = 0 ppm as compared to the parent strain KT01 and produced 5.6 g/L 3,4-AHBA in a glucose fed-batch culture., Conclusions: Our results revealed changes in the metabolic state in response to DO concentration and provided insights into oxygen supply during fermentation and the rational design of metabolic pathways for improved production of related amino acids and their derivatives., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
56. A Multicentre Retrospective Study of Nivolumab Plus Ipilimumab for Untreated Metastatic Renal Cell Carcinoma.
- Author
-
Kato R, Kojima T, Sazuka T, Yamamoto H, Fukuda S, Yamana K, Sugino Y, Hamamoto S, Nakaigawa N, Kabu K, Murakami H, and Obara W
- Subjects
- Aged, Aged, 80 and over, Carcinoma, Renal Cell mortality, Female, Humans, Ipilimumab pharmacology, Kidney Neoplasms mortality, Male, Middle Aged, Neoplasm Metastasis, Nivolumab pharmacology, Retrospective Studies, Survival Rate, Carcinoma, Renal Cell drug therapy, Ipilimumab therapeutic use, Kidney Neoplasms drug therapy, Nivolumab therapeutic use
- Abstract
Background/aim: To evaluate the effectiveness and safety of nivolumab plus ipilimumab for untreated metastatic renal cell carcinoma in real-world clinical practice in Japan based on 1-year follow-up results., Patients and Methods: This multicentre, retrospective study analysed 45 metastatic renal cell carcinoma patients who received nivolumab plus ipilimumab between August 2018 and January 2019 in Japan. Data were extracted from patients' medical records. Subgroup analyses were performed based on baseline demographic data and treatment history., Results: The objective response rate was 42.5% (complete response rate: 10.0%). The 12-month overall survival rate was 81.4% and the progression-free survival rate was 56.1%. Thirty-five patients (77.8%) showed any grade treatment-related adverse events and 17 (37.8%) showed grade ≥3 treatment-related adverse events, with no significant difference in safety between subgroups., Conclusion: The effectiveness and safety of nivolumab plus ipilimumab in real-world clinical practice with 1-year follow-up were comparable with those of the CheckMate 214 trial., (Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
57. Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patients.
- Author
-
Kanesaka M, Sakamoto S, Yamada Y, Rii J, Maimaiti M, Sazuka T, Imamura Y, Komiya A, Akakura K, Ikehara Y, Nakatsu H, and Ichikawa T
- Abstract
Background: To identify the real high-risk group among Japanese de novo metastatic prostate cancer patients who fit CHAARTED or LATITUDE criteria., Methods: We retrospectively studied patients who fitted CHAARTED (292 patients) and LATITUDE (294 patients) criteria from Japanese multi-institutions. All patients received androgen deprivation therapy with bicalutamide as an initial treatment. Factors related to overall survival (OS) and progression-free survival were statistically analyzed., Results: The median OS was 55.5 months and 60.0 months in patients who met the CHAARTED and the LATITUDE criteria, respectively. In patients who met CHAARTED criteria, lactate dehydrogenase (LDH) (hazard ratio (HR) 2.63, P < 0.0001) and C-reactive protein (CRP) (HR 1.65, P = 0.042) were independent risk factors for OS. In patients who met the LATITUDE criteria, Gleason score (GS) ≥9 (HR 1.77, P = 0.0326) and LDH (HR 2.62, P < 0.0001) were independent risk factors for OS. Modified CHAARTED criteria by adding LDH and CRP showed a significant difference in OS (HR 2.55, P < 0.0001) with a comparative median OS (31.8 months) to placebo of CHAARTED trial (32.2 months). Modified LATITUDE criteria by adding GS ≥9 and LDH showed a significant difference in OS (HR 2.66, P < 0.0001) with a comparative median OS (32.7 months) to placebo of LATITUDE trial (34.7 months)., Conclusion: Modified criteria may potentially elucidate the true "high volume" and "high risk" patients in the Japanese cohort who require early intensive therapy., Competing Interests: None declared., (© 2021 Asian Pacific Prostate Society. Publishing services by Elsevier B.V.)
- Published
- 2021
- Full Text
- View/download PDF
58. Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy.
- Author
-
Iida K, Miyake M, Murakami K, Komiyama M, Okajima E, Sazuka T, Nishiyama N, Yasumoto H, Kimura T, Ito A, Shiga K, Yamagishi A, Kikuchi H, Sugimoto M, Taoka R, Kobayashi T, Kojima T, Kitamura H, Nishiyama H, and Fujimoto K
- Subjects
- Cystectomy, Humans, Neoplasm Recurrence, Local, Retrospective Studies, BCG Vaccine therapeutic use, Urinary Bladder Neoplasms drug therapy, Urinary Bladder Neoplasms surgery
- Abstract
Background: Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) is a newly defined subtype that is unlikely to benefit from BCG rechallenge. Radical cystectomy is currently recommended for BCG-unresponsive NMIBC; however, a certain proportion of these patients can be managed with treatments other than that. Herein, we conducted a multicenter retrospective study to analyze the clinical outcomes of BCG-unresponsive NMIBC patients who did not receive radical cystectomy., Methods: Of the 141 BCG-unresponsive NMIBC patients, 94 (66.7%) received treatment except radical cystectomy. Survival outcomes were calculated from the date of diagnosis using the Kaplan-Meier method and compared using the log-rank test. Prognostic factors were identified using the multivariate Cox regression model. This group was further classified into three groups according to the number of risk factors, and survival outcomes were compared., Results: Multivariate analyses identified low estimated glomerular filtration rate (< 45 ml/min/1.73 m
2 ) and large tumor size (≥ 30 mm) before BCG induction as independent poor prognostic factors for progression-free survival and overall survival, while the latter was also an independent factor for cancer-specific survival. The presence of variant histology was an independent poor prognostic factor for overall survival. The high-risk non-cystectomy group showed a significantly poor prognosis for progression-free survival (hazard ratio: 7.61, 95% confidence interval: 2.11-27.5), cancer-specific survival (10.4, 0.54-70.02), and overall survival (8.28, 1.82-37.7)., Conclusions: Our findings suggest that patients with renal impairment and large tumors should undergo radical cystectomy if the complications and intentions of the patients allow so., (© 2021. Japan Society of Clinical Oncology.)- Published
- 2021
- Full Text
- View/download PDF
59. Expression of tertiary lymphoid structure in deferred cytoreductive nephrectomy of metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.
- Author
-
Sazuka T, Fujimoto A, Sato H, Arai T, Imamura Y, Sakamoto S, Ikeda JI, and Ichikawa T
- Abstract
Introduction: Tertiary lymphoid structure expression and immune checkpoint inhibitors have been attracting attention, and their relationship with renal cell carcinoma is controversial., Case Presentation: Two patients with nivolumab plus ipilimumab treatment response for metastatic renal cell carcinoma underwent cytoreductive nephrectomy and regional lymph node dissection. In both cases, the renal tumor site expressed tertiary lymphoid structures. Despite the absence of treatment after a deferred cytoreductive nephrectomy and the short postoperative observation period, the patients still survived., Conclusion: Tertiary lymphoid structures were expressed in deferred cytoreductive nephrectomy specimen in cases treated with nivolumab plus ipilimumab., Competing Interests: The authors declare no conflict of interest., (© 2021 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association.)
- Published
- 2021
- Full Text
- View/download PDF
60. Editorial Comment from Dr Sazuka to Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan.
- Author
-
Sazuka T
- Subjects
- Hospitals, Humans, Japan epidemiology, Kidney Pelvis, Registries, Carcinoma, Transitional Cell epidemiology, Ureteral Neoplasms epidemiology, Urinary Bladder Neoplasms, Urologic Neoplasms epidemiology
- Published
- 2021
- Full Text
- View/download PDF
61. Successful treatment of metastatic bladder cancer by gemcitabine-cisplatin re-challenge after pembrolizumab.
- Author
-
Arai T, Takeuchi N, Sazuka T, Sato H, Imamura Y, Sakamoto S, Komiya A, and Ichikawa T
- Abstract
Introduction: The advent of pembrolizumab has contributed to improved treatment outcomes for metastatic urothelial carcinoma, but the outcomes of treatments after second-line treatment have not been established., Case Presentation: A 72-year-old man was referred to our hospital with gross hematuria and diagnosed with suspicion of bladder cancer cT1N0M0. Transurethral resection of the bladder tumor was performed, but local recurrence and multiple lung metastases appeared 5 months after surgery. Although gemcitabine-cisplatin was performed as first-line chemotherapy, the local lesion increased, and pembrolizumab was used as a second-line treatment. Pembrolizumab was also ineffective; however, re-challenge with gemcitabine-cisplatin as third-line treatment produced a good therapeutic effect., Conclusion: We report a successful case in which gemcitabine-cisplatin re-challenge after pembrolizumab therapy was effective in metastatic bladder cancer. Re-administration of chemotherapy after immune checkpoint inhibitors may be a broadly effective treatment option., Competing Interests: The authors declare no conflict of interest., (© 2021 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association.)
- Published
- 2021
- Full Text
- View/download PDF
62. Efficacy and safety of second-line axitinib in octogenarians with metastatic renal cell carcinoma.
- Author
-
Nakai Y, Takeuchi A, Osawa T, Kojima T, Hara T, Sugimoto M, Eto M, Minami K, Ueda K, Ozawa M, Uemura M, Miyauchi Y, Ohba K, Kashiwagi A, Murakami M, Sazuka T, Yasumoto H, Morizane S, Kawasaki Y, Morooka D, Shimazui T, Yamamoto Y, Nakagomi H, Tomida R, Ito YM, Murai S, Kitamura H, Nishiyama H, and Shinohara N
- Subjects
- Aged, 80 and over, Axitinib adverse effects, Humans, Indazoles adverse effects, Protein Kinase Inhibitors therapeutic use, Treatment Outcome, Antineoplastic Agents adverse effects, Carcinoma, Renal Cell drug therapy, Kidney Neoplasms drug therapy
- Abstract
Competing Interests: Declaration of Competing Interest Mikio Sugimoto has received honoraria from Astellas, AstraZeneca, Janssen, and Takeda. Masatoshi Eto received honoraria for lectures from ONO, BMS, Pfizer, Novartis, MSD, and Chugai, and for research funding from ONO, Pfizer, Chugai, BMS, Eisai, Bayer and MSD. Akira Yokomizo has received honoraria from Astellas. Takamitsu Inoue reports scholarship endowments from BMS. Hiroyuki Nishiyama has received honoraria from Ono and Chugai; and received research funds from Ono, Takeda, and Astellas; and reports scholarship endowments from MSD, Astellas, AstraZeneca, and Chugai. Nobuo Shinohara has received honoraria from Bayer, Ono, and Astellas; and reports institutional research funding from Ono, Takeda, Sanofi, Taiho, and Astellas. The other authors have no conflicts of interest.
- Published
- 2021
- Full Text
- View/download PDF
63. Adrenalectomy in Japanese patients with subclinical Cushing syndrome: 1-mg dexamethasone suppression test to predict the surgical benefit.
- Author
-
Sato H, Imamura Y, Sakamoto S, Sugiura M, Arai T, Yamamoto S, Takeuchi N, Sazuka T, Nakamura K, Nagano H, Koide H, Tanaka T, Komiya A, and Ichikawa T
- Subjects
- Dexamethasone, Humans, Japan epidemiology, Retrospective Studies, Adrenalectomy, Cushing Syndrome diagnosis, Cushing Syndrome surgery
- Abstract
Objectives: To investigate whether the result of the 1-mg dexamethasone suppression test can predict the improvement of comorbidities after adrenalectomy in patients with subclinical Cushing syndrome., Methods: This retrospective study included 117 subclinical Cushing syndrome patients who underwent adrenalectomy. The numbers of prescribed drugs for metabolic comorbidities and the clinical variables at diagnosis were compared with those at the follow up. Patients were classified into subgroups according to the result of the 1-mg dexamethasone suppression test., Results: Significant improvements in blood pressure, serum cholesterol and body mass index were observed. Furthermore, a significant improvement in glycated hemoglobin was observed in patients with diabetes mellitus. These improvements led to a discontinuation or reduction of prescribed drugs after surgery. In addition, the greatest reduction of prescribed drugs was observed in patients whose serum cortisol levels were between 1.8 and 3.0 µg/dL after the 1-mg dexamethasone suppression test., Conclusions: The result of the 1-mg dexamethasone suppression test can be a useful factor predicting the improvement of comorbidities after adrenalectomy. Current data might give us a new insight into the decision-making for the treatment of subclinical Cushing syndrome., (© 2020 The Japanese Urological Association.)
- Published
- 2021
- Full Text
- View/download PDF
64. [A Case of Unresectable Colorectal Cancer with Complete Remission after Palliative Surgery Due to Continued Pharmacotherapy].
- Author
-
Tasaki K, Isozaki T, Fukunaga T, Sugamoto Y, Kuboshima M, Asai Y, Sazuka T, Arasawa T, Muto Y, Fujita E, Kimura M, and Matsubara H
- Subjects
- Colon, Sigmoid, Colostomy, Humans, Male, Middle Aged, Palliative Care, Intestinal Obstruction, Sigmoid Neoplasms
- Abstract
A 50s-year-old man was admitted to our hospital because of abdominal pain and vomitting. CT showed a thickened wall of the sigmoid colon, marked enlargement of the oral side, and a 30 mm tumor on the left lateral section of the liver. We diagnosed colonic obstruction due to sigmoid colon cancer with liver metastasis. We failed to place a colonic stent for decompression, so we performed a colostomy using the cecum. An exploratory laparoscopy was performed instead of curative surgery due to peritoneal disseminations, followed by chemotherapy and molecular targeted therapy. Although primary lesion, liver metastatic lesion and disseminated lesions were reduced by pharmacotherapy the patient developed a grade 2 skin disorder around the colostomy. Therefore, it was determined that molecular targeted therapy could not be continued. The resection of the primary lesion and closure of the colostomy were performed to continue pharmacotherapy. Pharmacotherapy was resumed after operation. The patient is currently getting complete remission, undergoing maintenance therapy with no skin disorders. In this case, surgery was performed as part of the multidisciplinary treatment. It suggested that palliative surgery might be an effective option in multidisciplinary treatment.
- Published
- 2021
65. The dominance model for heterosis explains culm length genetics in a hybrid sorghum variety.
- Author
-
Hashimoto S, Wake T, Nakamura H, Minamiyama M, Araki-Nakamura S, Ohmae-Shinohara K, Koketsu E, Okamura S, Miura K, Kawaguchi H, Kasuga S, and Sazuka T
- Subjects
- Alleles, Chromosome Mapping, Cloning, Molecular, Gene Expression, Genes, Dominant, Genes, Plant, Hybridization, Genetic, Japan, Plant Breeding, Genetic Association Studies, Hybrid Vigor genetics, Models, Genetic, Quantitative Trait Loci, Quantitative Trait, Heritable, Sorghum genetics
- Abstract
Heterosis helps increase the biomass of many crops; however, while models for its mechanisms have been proposed, it is not yet fully understood. Here, we use a QTL analysis of the progeny of a high-biomass sorghum F
1 hybrid to examine heterosis. Five QTLs were identified for culm length and were explained using the dominance model. Five resultant homozygous dominant alleles were used to develop pyramided lines, which produced biomasses like the original F1 line. Cloning of one of the uncharacterised genes (Dw7a) revealed that it encoded a MYB transcription factor, that was not yet proactively used in modern breeding, suggesting that combining classic dw1or dw3, and new (dw7a) genes is an important breeding strategy. In conclusion, heterosis is explained in this situation by the dominance model and a combination of genes that balance the shortness and early flowering of the parents, to produce F1 seed yields.- Published
- 2021
- Full Text
- View/download PDF
66. Prognostic Value of High-Sensitivity Modified Glasgow Prognostic Score in Castration-Resistant Prostate Cancer Patients Who Received Docetaxel.
- Author
-
Ando K, Sakamoto S, Saito S, Maimaiti M, Imamura Y, Sazuka T, Sato N, Komiya A, Anzai N, and Ichikawa T
- Abstract
The Glasgow prognostic score, a marker of systemic inflammation, is associated with clinical outcomes in different cancers including prostate cancer. However, there is no evidence for the relationship between the high-sensitivity modified Glasgow prognostic score (Hs-mGPS) in prostate cancer and its prognosis. This study aimed to investigate the prognostic significance of Hs-mGPS in castration-resistant prostate cancer (CRPC) treated with docetaxel. We retrospectively analyzed clinical datasets from 131 CRPC patients who received docetaxel treatment at Chiba University Hospital and a related hospital. Clinical factors including Hs-mGPS before docetaxel treatment were evaluated according to overall survival. The numbers of patients with Hs-mGPS of 0, 1, and 2 were 88, 30, and 13, respectively. The median prostate-specific antigen (PSA) level was 28.9 ng/mL. The median testosterone level was 13.0 ng/dL. The percentages of bone and visceral metastases were 80.8% and 10.2%, respectively. For overall survival, Hs-mGPS ≥ 1 (hazard ratio of 2.41; p = 0.0048), testosterone ≥ 13.0 ng/dL (hazard ratio of 2.23; p = 0.0117), and PSA ≥ 28.9 ng/mL (hazard ratio of 2.36; p = 0.0097) were significant poor prognostic factors in the multivariate analysis. The results of the two-group analysis showed that a higher Hs-mGPS was associated with high PSA, alkaline phosphatase, and testosterone levels. The median testosterone levels for Hs-mGPS of 0, 1, and 2 were 9.0, 16.5, and 23.0, respectively. Based on the multivariate analysis, we created a combined score with three prognostic factors: Hs-mGPS, testosterone, and PSA. The low-risk group (score of 0-1) showed a significantly longer overall survival compared to the intermediate-risk (score of 2-3) and high-risk (score of 4) groups ( p < 0.0001). Our results demonstrated that an elevated Hs-mGPS was an independent prognostic factor in CRPC patients treated with docetaxel therapy. Risk classification based on Hs-mGPS, testosterone, and PSA may be useful in predicting the prognosis of CRPC patients.
- Published
- 2021
- Full Text
- View/download PDF
67. [A Case of Intussusception Due to Ileal Malignant Lymphoma of AYA Generation].
- Author
-
Arasawa T, Fujita E, Muto Y, Sazuka T, Asai Y, Kuboshima M, Tasaki K, Sugamoto Y, Fukunaga T, Kimura M, Eguchi M, and Matsubara H
- Subjects
- Adolescent, Appendectomy, Child, Family Characteristics, Humans, Ileum, Male, Ileal Diseases etiology, Ileal Diseases surgery, Ileal Neoplasms complications, Ileal Neoplasms surgery, Intussusception etiology, Intussusception surgery
- Abstract
The case is a 17-year-old man. He had complained of right lower abdominal pain for a week. He had no symptoms such as fever, weight loss, or night sweats. He was diagnosed with intussusception by abdominal contrast-enhanced CT and was hospitalized. The day after hospitalization, lower gastrointestinal endoscopy was performed, and a tumor 25 mm in size was found in the invagination of the ileum. Intussusception was recovered by intestinal scope insufflation, and the tumor was found to be a type 1 tumor located approximately 5 cm proximal to the Bauhin's valve. On day 17 of hospitalization, he had intussusception again at the time of surgery, and performed laparoscopic reduction before performing laparoscopy-assisted partial resection of the small intestine and appendectomy. The postoperative course was good and he was discharged on POD12(on day 29 of hospitalization). Histopathological diagnosis was diffuse large B-cell lymphoma(DLBCL), and chemotherapy was to be administered at the referral hospital. In intussusception of the adolescents and young adults(AYA)generation, such as this case outside of childhood, it is necessary to treat the patient with consideration for the presence of neoplastic lesions such as malignant lymphoma. We report our case with some literature considerations.
- Published
- 2021
68. [A Case of Rectal Cancer with Collet-Sicard Syndrome].
- Author
-
Arasawa T, Miyauchi H, Fujita E, Muto Y, Sazuka T, Asai Y, Kuboshima M, Tasaki K, Sugamoto Y, Fukunaga T, Kimura M, and Matsubara H
- Subjects
- Female, Humans, Magnetic Resonance Imaging, Syndrome, Bone Neoplasms, Cranial Nerve Diseases, Rectal Neoplasms complications, Rectal Neoplasms therapy
- Abstract
The case was a woman in her 50s. Total pelvic resection was performed for advanced rectal cancer(cT4b[vagina]N3M0, cStage Ⅲc), after neoadjuvant chemoradiation therapy. Five months after the operation, she was unable to stand due to severe back pain. Spinal MRI revealed multiple bone metastases and lumbar fractures. In addition, dysphagia and dysarthria rapidly progressed almost simultaneously with back pain. Initially, brain metastasis was suspected, but head MRI revealed Collet-Sicard syndrome due to skull base metastasis. Irradiation to the skull base and high cervical spine, thoracolumbar spine was started. After irradiation, her back pain and cranial nerve symptoms improved. She was discharged and received palliative treatment. About a month after discharge, she was hospitalized for recurrent dysphagia and died on day 5 of hospitalization. Collet-Sicard syndrome is caused by damage to the cranial nerves Ⅸ to Ⅻ and is often caused by a tumor. Trauma, vasculitis, and internal carotid artery dissection have been reported as other causes. Symptoms such as hoarseness, dysarthria, tongue atrophy, dysphagia, and headache have been reported. Collet-Sicard syndrome due to bone metastasis of colorectal cancer were very rare, and we found only one other report. We report our case with some literature considerations.
- Published
- 2020
69. [A Case of Effective Peritoneo-Venous Shunt for Refractory Malignant Ascites in a Gastric Cancer Patient with Peritoneal Dissemination].
- Author
-
Sugamoto Y, Arasawa T, Fukunaga T, Tasaki K, Kuboshima M, Muto Y, Sazuka T, Kimura M, Asai Y, Fujita E, Ota T, and Matsubara H
- Subjects
- Ascites etiology, Ascites therapy, Female, Humans, Neoplasm Recurrence, Local, Quality of Life, Peritoneal Neoplasms, Peritoneovenous Shunt, Stomach Neoplasms complications, Stomach Neoplasms surgery
- Abstract
This paper reports a case of refractory ascites in a patient with gastric cancer. A peritoneo-venous shunt(PVS)was inserted in the patient, which contributed to extending the duration of home-based care as well as improving the patient's quality of life. The patient was a female in her 70s. She was diagnosed with gastric cancer and underwent total gastrectomy. Five years and 7 months after the surgery, she was diagnosed with peritoneal recurrence. Ascites temporarily decreased following chemotherapy, but gradually worsened thereafter. Since the patient required frequent puncture drainage for the ascites, cell-free concentrated ascites reinfusion therapy(CART)was performed. However, on the day prior to the scheduled second course of CART, marked abdominal distension was observed. Therefore, a PVS was inserted. No PVS-associated complications were observed. Following the insertion of the PVS, the patient's abdominal circumference and body weight markedly improved. Best supportive care(BSC)was provided to the patient as she became weak after undergoing several courses of chemotherapy on an outpatient basis. On the other hand, the PVS was working properly. The patient was able to continue her daily life activities at home. She died from the cancer after 164 days of the PVS insertion.
- Published
- 2020
70. [A Case of Rapidly Growing Breast Spindle Cell Carcinoma].
- Author
-
Urahama R, Serizawa Y, Kimura M, Fukunaga T, Sugamoto Y, Tasaki K, Kuboshima M, Asai Y, Sazuka T, Suitou H, and Matsubara H
- Subjects
- Aged, Female, Humans, Lymph Node Excision, Mastectomy, Neoplasm Recurrence, Local, Breast Neoplasms surgery, Carcinoma, Ductal, Breast surgery
- Abstract
We report a case of rapidly growing breast spindle cell carcinoma. The case was a 69-year-old female. Her chief complaint was right breast pain. She was being followed after surgery for left breast cancer but was seen because of right breast pain. In the right mammary gland CD area, a 27×27 mm large unclear mass lesion was observed, which had not been seen half a year prior. Right mastectomy and axillary dissection were performed following a preoperative diagnosis of pT2N1M0, pStage ⅡB ductal carcinoma. Currently, 2 years and 2 months have passed since the operation, and recurrence has not been observed. Case reports of rapidly growing breast spindle cell carcinoma are occasionally found, but no literature specifically defines acute growth. Here, we defined rapid growth using the tumor doubling time(DT)proposed by Gerstenberg et al. Of all the reported cases of breast spindle cell carcinoma, the DT was fewer than 90 days in most cases. Breast spindle cell carcinoma demonstrates rapid grown compared to normal breast cancer.
- Published
- 2020
71. Relationship between post-void residual urine volume, preoperative pyuria and intravesical recurrence after transurethral resection of bladder carcinoma.
- Author
-
Sazuka T, Sakamoto S, Imamura Y, Nakamura K, Yamamoto S, Arai T, Takeuchi N, Komiya A, Teishima J, and Ichikawa T
- Subjects
- Administration, Intravesical, BCG Vaccine therapeutic use, Humans, Male, Neoplasm Recurrence, Local epidemiology, Retrospective Studies, Carcinoma, Pyuria epidemiology, Pyuria etiology, Urinary Bladder Neoplasms drug therapy, Urinary Bladder Neoplasms surgery
- Abstract
Objectives: To evaluate the relationship between residual urine volume, pyuria and bladder carcinoma recurrence., Methods: The clinical data of 305 patients who had post-void residual urine volume measured and preoperative pyuria were retrospectively collected. The patients were classified into three risk groups based on the presence of residual urine and pyuria: good (negative residual urine and pyuria), intermediate (positive residual urine or pyuria) and poor (positive residual urine and pyuria). Predictive factors for intravesical recurrence-free survival were statistically analyzed using Cox proportional hazard models and Kaplan-Meier methods. The propensity score matching method was used to adjust the patients' backgrounds., Results: The median follow-up period for all patients was 44 months. The presence of residual urine (P = 0.0164) and pyuria (P = 0.0233) were two independent prognostic factors for recurrence. After patients were classified into risk groups, the poor-risk group showed significantly shorter recurrence-free survival compared with that of the good- (P = 0.0002) and intermediate-risk groups (P = 0.0090). Even after matching, the presence of residual urine was related to short recurrence-free survival in male patients (P = 0.0012). When stratified by European Organization for Research and Treatment of Cancer risk groups, the presence of pyuria was related to short recurrence-free survival, especially for intermediate-risk patients without bacillus Calmette-Guérin treatment., Conclusions: Post-void residual urine and preoperative pyuria are two risks for recurrence-free survival in non-muscle-invasive bladder cancer., (© 2020 The Japanese Urological Association.)
- Published
- 2020
- Full Text
- View/download PDF
72. Complete and Draft Genome Sequences of Amino Acid-Producing Corynebacterium glutamicum Strains ATCC 21799 and ATCC 31831 and Their Genomic Islands.
- Author
-
Kawaguchi H, Sazuka T, and Kondo A
- Abstract
We determined the complete and draft genome sequences of two strains of Corynebacterium glutamicum and revealed their genomic islands (GEIs). The two strains, ATCC 21799 and ATCC 31831, were found to have 3,079 and 3,109 coding sequences, respectively, with 13 GEIs each not present in the reference strain, ATCC 13032., (Copyright © 2020 Kawaguchi et al.)
- Published
- 2020
- Full Text
- View/download PDF
73. Prognostic factors influencing overall survival in de novo oligometastatic prostate cancer patients.
- Author
-
Rii J, Sakamoto S, Yamada Y, Takeshita N, Yamamoto S, Sazuka T, Imamura Y, Nakamura K, Komiya A, Komaru A, Fukasawa S, Nakatsu H, Akakura K, and Ichikawa T
- Subjects
- Aged, Aged, 80 and over, Androgen Antagonists therapeutic use, Humans, Japan epidemiology, Kaplan-Meier Estimate, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Staging, Prognosis, Progression-Free Survival, Randomized Controlled Trials as Topic, Retrospective Studies, Survival Rate, Bone Neoplasms mortality, Bone Neoplasms secondary, Prostatic Neoplasms mortality, Prostatic Neoplasms pathology
- Abstract
Background: Oligometastatic cancer has been suggested as an intermediate state between localized disease and wide-ranging metastases. The clinical significance of local treatment in oligometastatic prostate cancer (PCa) has been a recent topic of interest. However, standard definitions of oligometastasis are lacking. Here we studied risk factors among Japanese de novo oligometastatic patients with PCa., Methods: We retrospectively assessed clinical data from 264 patients, including locally advanced (T3 or T4N0M0) cancer, lymph-node-positive cancer (T
any N1M0), and cancer with ≤10 bone metastases. All patients received androgen deprivation therapy only. The number of bone metastases and clinical factors were evaluated in association with overall survival (OS) and progression-free survival (PFS). The Mann-Whitney U test, Cox proportional hazard models, and Kaplan-Meier methods were used as statistical analyses., Results: Median age, PSA at baseline and OS were 74 years, 55.2 ng/mL, and 129.0 months, respectively. The cutoff for the number of bone metastases having the greatest impact on OS was ≥3 (hazard ratio [HR]: 2.67; P = .0001). In multivariate analysis, non-regional lymph node (LN) metastases (HR: 2.15; P = .0222), ISUP grade group (GG) 5 (HR: 2.04; P = .0186) and ≥3 bone metastases (HR: 1.82; P = .0390) were independent predictors of OS. In risk classification based on these factors, OS and PFS were significantly classifiable into poor (2-3 factors), intermediate (1 factor), and good (no factors) risk groups (P < .0001)., Conclusion: Not only the number of bone metastases, but also non-regional LN metastases predict OS in patients with de novo oligometastatic PCa., (© 2020 Wiley Periodicals LLC.)- Published
- 2020
- Full Text
- View/download PDF
74. Oncological outcomes of a multicenter cohort treated with axitinib for metastatic renal cell carcinoma.
- Author
-
Osawa T, Kojima T, Hara T, Sugimoto M, Eto M, Takeuchi A, Minami K, Nakai Y, Ueda K, Ozawa M, Uemura M, Miyauchi Y, Ohba K, Suzuki T, Anai S, Shindo T, Kusakabe N, Tamura K, Komiyama M, Goto T, Yokomizo A, Kohei N, Kashiwagi A, Murakami M, Sazuka T, Yasumoto H, Iwamoto H, Mitsuzuka K, Morooka D, Shimazui T, Yamamoto Y, Ikeshiro S, Nakagomi H, Morita K, Tomida R, Mochizuki T, Inoue T, Kitamura H, Yamada S, Ito YM, Murai S, Nishiyama H, and Shinohara N
- Subjects
- Aged, Antineoplastic Agents administration & dosage, Antineoplastic Agents adverse effects, Axitinib administration & dosage, Axitinib adverse effects, Carcinoma, Renal Cell mortality, Female, Humans, Kaplan-Meier Estimate, Kidney Neoplasms mortality, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Staging, Prognosis, Protein Kinase Inhibitors administration & dosage, Protein Kinase Inhibitors adverse effects, ROC Curve, Retreatment, Treatment Outcome, Antineoplastic Agents therapeutic use, Axitinib therapeutic use, Carcinoma, Renal Cell drug therapy, Carcinoma, Renal Cell pathology, Kidney Neoplasms drug therapy, Kidney Neoplasms pathology, Protein Kinase Inhibitors therapeutic use
- Abstract
The present study aimed to evaluate the efficacy of the real-world use of axitinib and to develop a prognostic model for stratifying patients who could derive long-term benefit from axitinib. This was a retrospective, descriptive study evaluating the efficacy of axitinib in patients with metastatic renal cell carcinoma that had been treated with 1 or 2 systemic antiangiogenic therapy regimens at 1 of 36 hospitals belonging to the Japan Urologic Oncology Group between January 2012 and February 2019. The primary outcome was overall survival (OS). Using a split-sample method, candidate variables that exhibited significant relationships with OS were chosen to create a model. The new model was validated using the rest of the cohort. In total, 485 patients were enrolled. The median OS was 34 months in the entire study population, whereas it was not reached, 27 months, and 14 months in the favorable, intermediate, and poor risk groups, respectively, according to the new risk classification model. The following 4 variables were included in the final risk model: the disease stage at diagnosis, number of metastatic sites at the start of axitinib therapy, serum albumin level, and neutrophil : lymphocyte ratio. The adjusted area under the curve values of the new model at 12, 36, and 60 months were 0.77, 0.82, and 0.82, respectively. The efficacy of axitinib in routine practice is comparable or even superior to that reported previously. The patients in the new model's favorable risk group might derive a long-term survival benefit from axitinib treatment., (© 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.)
- Published
- 2020
- Full Text
- View/download PDF
75. Soft coagulation in robot-assisted partial nephrectomy without renorrhaphy: Comparison with standard suture.
- Author
-
Nakamura K, Imamura Y, Yamamoto S, Sazuka T, Sakamoto S, and Ichikawa T
- Subjects
- Humans, Nephrectomy, Reference Standards, Suture Techniques, Sutures, Kidney Neoplasms surgery, Laparoscopy, Robotic Surgical Procedures, Robotics
- Published
- 2020
- Full Text
- View/download PDF
76. Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma.
- Author
-
Maimaiti M, Sakamoto S, Yamada Y, Sugiura M, Rii J, Takeuchi N, Imamura Y, Furihata T, Ando K, Higuchi K, Xu M, Sazuka T, Nakamura K, Kaneda A, Kanai Y, Kyprianou N, Ikehara Y, Anzai N, and Ichikawa T
- Subjects
- Benzoxazoles pharmacology, Cell Line, Tumor, Disease-Free Survival, Extracellular Signal-Regulated MAP Kinases metabolism, Female, Humans, Male, Neoplasm Proteins antagonists & inhibitors, Survival Rate, TOR Serine-Threonine Kinases metabolism, Tyrosine analogs & derivatives, Tyrosine pharmacology, Urinary Bladder Neoplasms drug therapy, Urinary Bladder Neoplasms pathology, Gene Expression Regulation, Neoplastic, Large Neutral Amino Acid-Transporter 1 biosynthesis, MAP Kinase Signaling System, Neoplasm Proteins biosynthesis, Urinary Bladder Neoplasms metabolism, Urinary Bladder Neoplasms microbiology
- Abstract
L-type amino acid transporter 1 (LAT1) plays a role in transporting essential amino acids including leucine, which regulates the mTOR signaling pathway. Here, we studied the expression profile and functional role of LAT1 in bladder cancer. Furthermore, the pharmacological activity of JPH203, a specific inhibitor of LAT1, was studied in bladder cancer. LAT1 expression in bladder cancer cells was higher than that in normal cells. SiLAT1 and JPH203 suppressed cell proliferative and migratory and invasive abilities in bladder cancer cells. JPH203 inhibited leucine uptake by > 90%. RNA-seq analysis identified insulin-like growth factor-binding protein-5 (IGFBP-5) as a downstream target of JPH203. JPH203 inhibited phosphorylation of MAPK / Erk, AKT, p70S6K and 4EBP-1. Multivariate analysis revealed that high LAT1 expression was found as an independent prognostic factor for overall survival (HR3.46 P = 0.0204). Patients with high LAT1 and IGFBP-5 expression had significantly shorter overall survival periods than those with low expression (P = 0.0005). High LAT1 was related to the high Grade, pathological T stage, LDH, and NLR. Collectively, LAT1 significantly contributed to bladder cancer progression. Targeting LAT1 by JPH203 may represent a novel therapeutic option in bladder cancer treatment.
- Published
- 2020
- Full Text
- View/download PDF
77. Left ileal conduit: A case report.
- Author
-
Nakamura K, Matsui K, Wakai K, Sazuka T, Imamura Y, Sakamoto S, Sekita N, and Ichikawa T
- Abstract
Introduction: When ileal conduit construction is performed for urinary tract drainage during radical cystectomy, the conduit is usually constructed in the right lower abdomen. However, no reports have described ileal conduit construction in the left lower abdomen when it cannot be performed on the right side. In addition, some ingenuity is necessary for construction on the left., Case Presentation: A 75-year-old woman visited our hospital with chief complaint of gross hematuria. Computed tomography and cystoscopy showed a huge bladder tumor, and blood analysis showed anemia. The patient was treated by radical cystectomy with ileal conduit construction. An ileal conduit was constructed in the left lower abdomen; it was impossible to construct in the right lower abdomen because of the abdominal wall scar hernia due to the past open surgery., Conclusion: We herein reported a patient who underwent ileal conduit for urinary diversion on the left side of low abdominal wall., Competing Interests: The authors declare no conflict of interest., (© 2019 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association.)
- Published
- 2019
- Full Text
- View/download PDF
78. Impact of post-void residual urine volume on intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
- Author
-
Sazuka T, Sakamoto S, Nakamura K, Imamura Y, Yamamoto S, Komiya A, and Ichikawa T
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma, Transitional Cell mortality, Cystoscopy, Disease-Free Survival, Female, Follow-Up Studies, Humans, Kidney Neoplasms mortality, Male, Middle Aged, Postoperative Period, Retrospective Studies, Risk Assessment methods, Risk Factors, Ureteral Neoplasms mortality, Urinary Bladder physiopathology, Urination physiology, Carcinoma, Transitional Cell surgery, Kidney Neoplasms surgery, Neoplasm Recurrence, Local epidemiology, Nephroureterectomy, Ureteral Neoplasms surgery, Urinary Bladder diagnostic imaging
- Abstract
Objective: To examine the impact of post-void residual urine volume on the risk of postoperative recurrence of intravesical carcinoma in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy., Methods: We retrospectively reviewed the data of 81 patients who were admitted to Chiba University Graduate School of Medicine Hospital and underwent nephroureterectomy for upper urinary tract urothelial carcinoma without bladder carcinoma. We assessed the predictive factors for intravesical recurrence after nephroureterectomy in all patients. Next, we compared patients with and without a residual urine volume using propensity score-matching analysis. The presence of a residual urine volume was defined as ≥30 mL., Results: The median follow-up period among all patients was 48 months. The presence of pyuria and a residual urine volume were associated with bladder recurrence in the multivariate analysis. A total of 19 patients each were selected after matching, and we confirmed a significant difference between the presence and absence of a residual urine volume (P = 0.0291). The 2-year postoperative recurrence-free rate of patients with and without a residual urine volume was 32% and 82%, respectively., Conclusions: This is the first study to evaluate the post-void residual urine volume and intravesical recurrence rate after nephroureterectomy for upper urinary tract urothelial carcinoma. The presence of residual urine might be a risk factor for postoperative recurrence of intravesical carcinoma., (© 2019 The Japanese Urological Association.)
- Published
- 2019
- Full Text
- View/download PDF
79. Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma.
- Author
-
Higuchi K, Sakamoto S, Ando K, Maimaiti M, Takeshita N, Okunushi K, Reien Y, Imamura Y, Sazuka T, Nakamura K, Matsushima J, Furihata T, Ikehara Y, Ichikawa T, and Anzai N
- Subjects
- Benzoxazoles pharmacology, Biomarkers, Tumor metabolism, Carcinoma, Renal Cell drug therapy, Carcinoma, Renal Cell pathology, Cell Line, Tumor, Cell Movement drug effects, Cell Proliferation drug effects, Female, Humans, Kidney Neoplasms drug therapy, Kidney Neoplasms pathology, Male, Middle Aged, Prognosis, Progression-Free Survival, Retrospective Studies, Tyrosine analogs & derivatives, Tyrosine pharmacology, Carcinoma, Renal Cell metabolism, Kidney Neoplasms metabolism, Large Neutral Amino Acid-Transporter 1 metabolism
- Abstract
Large neutral amino acid transporter 1 (LAT1, SLC7A5) is abundantly expressed in various types of cancer, and it has been thought to assist cancer progression through its activity for uptake of neutral amino acids. However, the roles of LAT1 in renal cell carcinoma (RCC) prognosis and treatment remain uncharacterized. Therefore, we first retrospectively examined the LAT1 expression profile and its associations with clinical factors in RCC tissues (n = 92). The results of immunohistochemistry showed that most of the tissues examined (92%) had cancer-associated LAT1 expression. Furthermore, the overall survival (OS) and progression-free survival (PFS) were shorter in patients with high LAT1 expression levels than in those with low LAT1 expression levels (P = 0.018 and 0.014, respectively), and these associations were further strengthened by the results of univariate and multivariate analyses. Next, we tested the effects of JPH203, which is a selective LAT1 inhibitor, on RCC-derived Caki-1 and ACHN cells. It was found that JPH203 inhibited the growth of these cell types in a dose-dependent manner. Moreover, JPH203 clearly suppressed their migration and invasion activities. Thus, our results show that LAT1 has a great potential to become not only a prognosis biomarker but also a therapeutic target in RCC clinical settings.
- Published
- 2019
- Full Text
- View/download PDF
80. Intravesical irrigation might prevent bladder recurrence in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
- Author
-
Yamamoto S, Sakamoto S, Imamura Y, Sazuka T, Nakamura K, Inoue T, Chiba K, Miyazaki K, Inoue A, Nagata M, and Ichikawa T
- Subjects
- Administration, Intravesical, Aged, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Neoplasm Recurrence, Local epidemiology, Neoplasm Seeding, Retrospective Studies, Therapeutic Irrigation methods, Urinary Bladder, Water administration & dosage, Carcinoma, Transitional Cell surgery, Kidney Neoplasms surgery, Neoplasm Recurrence, Local prevention & control, Nephroureterectomy methods, Saline Solution administration & dosage, Ureteral Neoplasms surgery
- Abstract
Objectives: To examine the effectiveness of intravesical irrigation with physiological saline solution or distilled water for the prevention of bladder recurrence in patients undergoing laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma., Methods: This retrospective study involved 109 upper urinary tract urothelial carcinoma patients who underwent laparoscopic nephroureterectomy, and were evaluated at Chiba University Hospital and Yokohama Rosai Hospital between 2001 and 2018. We investigated the outcomes and analyzed various clinical factors including with or without intravesical irrigation related to bladder carcinoma recurrence after surgery. Physiological saline solution or distilled water was used for irrigation, which was carried out only during surgery., Results: The median follow-up period after surgery was 26.1 months. Bladder recurrence was confirmed within 2 years for 45 of the 109 patients in the present study. Irrigation was carried out for 48 cases (distilled water, 26 patients; physiological saline solution, 22 patients). Tumor grade (G1-2 vs G3; P = 0.05) and intravesical irrigation (yes vs no; P = 0.0058) were related to bladder recurrence on univariate analyses. On multivariate analyses, intravesical irrigation was the independent factor involved in the prevention of bladder recurrence (P = 0.0051). Comparison between the irrigation and non-irrigation groups showed that bladder recurrence rates were significantly lower in the irrigation group (irrigation group vs non-irrigation group: 25.0% vs 52.5%, P = 0.0066). There was no significant difference in the recurrence rate between the two solutions used for irrigation., Conclusions: Intravesical irrigation during surgery of upper urinary tract urothelial carcinoma might decrease postoperative bladder recurrence rates., (© 2019 The Japanese Urological Association.)
- Published
- 2019
- Full Text
- View/download PDF
81. Usefulness of Renal Autotransplantation for Radiotherapy-induced Renovascular Hypertension.
- Author
-
Wakabayashi S, Takaoka H, Miyauchi H, Sazuka T, Saito Y, Sugimoto K, Funabashi N, Ichikawa T, Matsubara H, and Kobayashi Y
- Subjects
- Adult, Child, Child, Preschool, Female, Humans, Kidney Transplantation methods, Transplantation, Autologous methods, Treatment Outcome, Young Adult, Hypertension etiology, Hypertension surgery, Hypertension, Renovascular etiology, Hypertension, Renovascular surgery, Neuroblastoma radiotherapy, Radiotherapy adverse effects, Renal Artery Obstruction etiology, Renal Artery Obstruction surgery
- Abstract
We experienced a young woman with congestive heart failure (CHF) caused by renovascular hypertension (RVH) and subsequent hypertensive heart disease. She underwent tumor resection and intraoperative radiation therapy because of neuroblastoma at age 2. She was diagnosed with RVH and hypertensive heart disease due to radiation-induced renal artery stenosis at age 12. Thereafter, she was hospitalized with CHF caused by uncontrolled RVH at age 19, and renal autotransplantation with extraction of left kidney was performed after the recovery of CHF. Her blood pressure has been well controlled without CHF readmission during four years of follow-up after the operation.
- Published
- 2019
- Full Text
- View/download PDF
82. [Long-Term Survival of a Rectal Cancer Patient with Virchow Lymph Node Metastasis, Liver Metastasis, and Para-Aortic Lymph Node Metastasis].
- Author
-
Urahama R, Toyozumi T, Kamata T, Isozaki T, Sazuka T, Asai Y, Kuboshima M, Tasaki K, Sugamoto Y, Fukunaga T, Kimura M, and Matsubara H
- Subjects
- Aged, Female, Humans, Lymph Node Excision, Lymph Nodes, Neoplasm Recurrence, Local, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Liver Neoplasms drug therapy, Liver Neoplasms secondary, Rectal Neoplasms drug therapy, Rectal Neoplasms pathology, Rectal Neoplasms surgery
- Abstract
A 67-year-old female was diagnosed with Stage Ⅳ rectal cancer with paraaortic lymph node metastasis. The patient underwent Hartmann's operation with D3 lymph node and paraaortic lymph node dissection. Postoperative chemotherapy with FOLFIRI was then administered for 1 year. However, liver metastasis developed, for which partial hepatectomy was performed. Postoperative chemotherapy with S-1(20 courses)was then administered. Three years and 11 months following the first operation, lymph node metastases developed and resection of lymph nodes(No. 12p, No. 16b1int)was performed. Postoperative chemotherapy with capecitabine(Cape)(8 courses)was then administered. Five years and 7 months following the first operation, Virchow lymph node metastasis developed. Despite chemotherapy with Cape and bevacizumab (Bmab), Virchow lymph node swelling recurred, and resection was performed. Nine years and 4 months following the first operation, lymph node metastases developed, and resection of lymph nodes(Virchow, No. 16b1int)was performed. Postoperative chemotherapy with S-1(8 courses)was then administered. At present, 11 years and 4 months after the first operation, the patient, whose chemotherapy has been discontinued, is alive without recurrence.
- Published
- 2018
83. [Pulmonary Metastasis Resection Twice after Curative Resection of Esophageal Cancer-A Long-Term Survival Case].
- Author
-
Urahama R, Murakami K, Kamata T, Isozaki T, Sazuka T, Asai Y, Kuboshima M, Tasaki K, Sugamoto Y, Fukunaga T, Kimura M, and Matsubara H
- Subjects
- Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Retrospective Studies, Carcinoma, Squamous Cell secondary, Carcinoma, Squamous Cell surgery, Esophageal Neoplasms pathology, Esophageal Neoplasms surgery, Lung Neoplasms secondary, Lung Neoplasms surgery
- Abstract
The prognosis of patients with esophageal cancer recurrence is poor, and surgical treatment is rarely performed. Here, we report on a patient with long-term survival who underwent pulmonary metastasis resection twice after curative resection of esophageal cancer. A 62-year-old male underwent curative resection of esophageal cancer after preoperative chemoradiotherapy. The histopathological diagnosis was poorly differentiated squamous cell carcinoma(pT2N1M0, fStage Ⅱ). Five months after the operation, right lung metastasis(right-S2)was detected. Accordingly, pulmonary metastasis resection was performed. Fourteen months after the initial operation, left lung metastases(left-S3/S6)were detected. The patient underwent resection again for the pulmonary metastases. The patient died of pneumonia without recurrence 8 years 3 months after the initial operation. In selected cases, surgical resection seems effective for treating distant esophageal cancer metastasis, suggesting that surgery should be an option in cases of accumulation of numerous distant metastases in esophageal cancer.
- Published
- 2018
84. [A Case of Colon Metastasis from Invasive Lobular Carcinoma of the Breast].
- Author
-
Sazuka T, Kimura M, Ikeda Y, Kamata T, Isozaki T, Urahama R, Tasaki K, Sugamoto Y, Watanabe Y, Asai Y, Fukunaga T, and Matsubara H
- Subjects
- Female, Humans, Middle Aged, Breast Neoplasms pathology, Carcinoma, Lobular secondary, Colonic Neoplasms secondary, Colonic Neoplasms therapy
- Abstract
The patient was a 48-year-old woman. She consulted our hospital with a chief complaint of vomiting. Colonoscopy showed stenosis and edematous mucosa, and biopsy was performed. Histological examination demonstrated the lesion to be colonic metastasis of breast cancer, invasive lobular carcinoma. Although colorectal metastasis of breast cancer has a poor prognosis and chemotherapy is considered as the main treatment modality, hormone therapy is also a treatment option depending on the condition.
- Published
- 2018
85. [A Case of HER2 Positive Locally Advanced Breast Cancer Successfully Treated with a Combination Therapy of Eribulin, Trastuzumab and Pertuzumab].
- Author
-
Sazuka T, Kimura M, Kamata T, Isozaki T, Urahama R, Tasaki K, Sugamoto Y, Watanabe Y, Asai Y, Fukunaga T, and Matsubara H
- Subjects
- Antibodies, Monoclonal, Humanized administration & dosage, Female, Furans administration & dosage, Humans, Ketones administration & dosage, Trastuzumab administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Breast Neoplasms drug therapy, Receptor, ErbB-2 analysis
- Abstract
The patient was an 82-year-oldwoman. She consultedour hospital with a chief complaint of left breast mass. MRI showed enhancedtumor with skin andextensive pectoral muscle invasion, so it was unresectable. Immunohistopathological analysis revealeda HER2-positive lesion. We administerederibulin, trastuzumab andpertuzumab, after which the tumor became resectable. Histological examination revealedremarkable response. Combination therapy of eribulin, trastuzumab andpertuzumab was well toleratedandconsid eredto be effective.
- Published
- 2018
86. [A Case of Gallbladder Jejunal Anastomosis and Duodenal Jejunal Anastomosis to Maintain QOL for an Elderly Patient with Pancreatic Cancer].
- Author
-
Isozaki T, Tasaki K, Kimura M, Fukunaga T, Sugamoto Y, Kuboshima M, Asai Y, Sazuka T, Watanabe Y, Urahama R, Kamata T, and Matsubara H
- Subjects
- Aged, Female, Gallbladder, Humans, Quality of Life, Anastomosis, Surgical, Biliary Tract Surgical Procedures, Pancreatic Neoplasms surgery
- Abstract
An 87-year-oldwoman was admittedto our hospital with abdominal pain andfever. Computedtomography showeda 25 mm tumor mass in the pancreatic headandshowedd ilatation of the pancreatic duct andcommon bile duct. She was diagnosed with obstructive cholangitis due to pancreatic head cancer. An endoscopic naso-biliary drainage(EUS)tube was inserted, and an endoscopic ultrasound(ENBD)examination was performed. At this time, duodenal perforation occurred, and an emergency operation was performed. During the laparotomy, perforation was found in the anterior wall of the duodenum. The contamination in the abdominal cavity and the degree of tissue damage in the duodenum were mild. Gall bladder jejunal andd uodenal jejunal anastomoses were performedfor biliary bypass andto close the perforation andbypass the gastrointestinal tract, respectively. She hadno postoperative complications andwas discharged 13 days postoperatively. Oral intake was possible after discharge, andthe patient returnedhome without complications. She died 5 months postoperatively. In this case, we performedbile duct andgastrointestinal bypass surgery prophylactically. Although this surgery will not be effective for all patients, we thought that it wouldbe useful for predicting the patient's future condition and for increasing the procedural options, even in case of emergency surgery.
- Published
- 2018
87. Repeated ethanol fermentation from membrane-concentrated sweet sorghum juice using the flocculating yeast Saccharomyces cerevisiae F118 strain.
- Author
-
Wijaya H, Sasaki K, Kahar P, Yopi, Kawaguchi H, Sazuka T, Ogino C, Prasetya B, and Kondo A
- Subjects
- Edible Grain, Flocculation, Saccharomyces cerevisiae, Ethanol chemistry, Fermentation, Sorghum
- Abstract
The aim of this study was to construct a cost-effective method for repeated bioethanol production using membrane (ultrafiltration permeation and nanofiltration concentration)-concentrated sweet sorghum juice by using flocculent Saccharomyces cerevisiae F118 strain. With low initial dry cell concentrations at around 0.28-0.35 g L
-1 , the S. cerevisiae F118 strain provided an ethanol titer of 86.19 ± 1.15 g L-1 (theoretical ethanol yield of 70.77%), which was higher than the non-flocculent S. cerevisiae BY4741 strain at 33.92 ± 0.99 g L-1 after 24 h fermentation. This result was correlated with higher gene expressions of the sucrose-hydrolysing enzyme invertase, sugar phosphorylation, and pyruvate-to-ethanol pathways in the F118 strain compared with the BY4741 strain. Sequential fed-batch fermentation was conducted, and the F118 strain was easily separated from the fermentation broth via the formation of flocs and sediment. After the 5th cycle of fermentation with the F118 strain, the ethanol concentration reached 100.37 g L-1 ., (Copyright © 2018 Elsevier Ltd. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
88. Transcriptional switch for programmed cell death in pith parenchyma of sorghum stems.
- Author
-
Fujimoto M, Sazuka T, Oda Y, Kawahigashi H, Wu J, Takanashi H, Ohnishi T, Yoneda JI, Ishimori M, Kajiya-Kanegae H, Hibara KI, Ishizuna F, Ebine K, Ueda T, Tokunaga T, Iwata H, Matsumoto T, Kasuga S, Yonemaru JI, and Tsutsumi N
- Subjects
- Arabidopsis cytology, Arabidopsis genetics, Arabidopsis metabolism, Base Sequence, Carbohydrates analysis, Chromosome Mapping, Chromosomes, Plant genetics, Geography, Phylogeny, Plant Proteins classification, Plant Proteins metabolism, Plant Stems cytology, Plant Stems metabolism, Sequence Homology, Nucleic Acid, Sorghum cytology, Sorghum metabolism, Transcription Factors genetics, Transcription Factors metabolism, Apoptosis genetics, Gene Expression Regulation, Plant, Plant Proteins genetics, Plant Stems genetics, Sorghum genetics
- Abstract
Pith parenchyma cells store water in various plant organs. These cells are especially important for producing sugar and ethanol from the sugar juice of grass stems. In many plants, the death of pith parenchyma cells reduces their stem water content. Previous studies proposed that a hypothetical D gene might be responsible for the death of stem pith parenchyma cells in Sorghum bicolor , a promising energy grass, although its identity and molecular function are unknown. Here, we identify the D gene and note that it is located on chromosome 6 in agreement with previous predictions. Sorghum varieties with a functional D allele had stems enriched with dry, dead pith parenchyma cells, whereas those with each of six independent nonfunctional D alleles had stems enriched with juicy, living pith parenchyma cells. D expression was spatiotemporally coupled with the appearance of dead, air-filled pith parenchyma cells in sorghum stems. Among D homologs that are present in flowering plants, Arabidopsis ANAC074 also is required for the death of stem pith parenchyma cells. D and ANAC074 encode previously uncharacterized NAC transcription factors and are sufficient to ectopically induce programmed death of Arabidopsis culture cells via the activation of autolytic enzymes. Taken together, these results indicate that D and its Arabidopsis ortholog, ANAC074 , are master transcriptional switches that induce programmed death of stem pith parenchyma cells. Thus, targeting the D gene will provide an approach to breeding crops for sugar and ethanol production., Competing Interests: Conflict of interest statement: J.-i. Yonemaru, H.K., T.M., N.T., and S.K. are listed on a patent based on this work (Japanese patent P2015-025241), which was filed by NARO.
- Published
- 2018
- Full Text
- View/download PDF
89. Contralateral adrenal width predicts the duration of prolonged post-surgical steroid replacement for subclinical Cushing syndrome.
- Author
-
Sugiura M, Imamura Y, Kawamura K, Yamamoto S, Sazuka T, Nakamura K, Sakamoto S, Nagano H, Koide H, Tanaka T, Imamoto T, Komiya A, and Ichikawa T
- Subjects
- Adrenal Glands diagnostic imaging, Adrenal Glands metabolism, Adrenal Glands surgery, Adult, Aged, Cushing Syndrome blood, Feasibility Studies, Female, Humans, Hydrocortisone blood, Magnetic Resonance Imaging, Male, Middle Aged, Organ Size, Postoperative Period, Predictive Value of Tests, Retrospective Studies, Time Factors, Tomography, X-Ray Computed, Treatment Outcome, Adrenal Glands anatomy & histology, Adrenalectomy adverse effects, Cushing Syndrome surgery, Hormone Replacement Therapy methods, Hydrocortisone therapeutic use
- Abstract
Objectives: To identify pre-treatment factors affecting the duration of post-surgical steroid replacement in patients undergoing adrenalectomy for subclinical Cushing syndrome., Methods: The present retrospective analysis included 64 patients who underwent unilateral laparoscopic adrenalectomy for subclinical Cushing syndrome. Adrenal tumor and contralateral adrenal sizes together with various clinical factors were studied in association with the duration of post-surgical steroid replacement. Adrenal tumor and contralateral adrenal size were measured at the level of the maximum transverse plane of the adrenal glands using computed tomography scan or magnetic resonance imaging. Cox's proportional hazards model was used for the statistical analysis., Results: All 64 patients were treated with post-surgical steroid replacement after adrenalectomy. The median duration of the steroid treatment was 6 months. When assessing the duration of post-surgical steroid replacement, contralateral adrenal volume <0.745 cm
3 , contralateral adrenal width <6.15 mm and serum cortisol after a 1-mg dexamethasone suppression test >2.65 μg/dL were significant predictors of prolonged post-surgical steroid treatment on univariate analysis. On multivariate analysis, contralateral adrenal width <6.15 mm was the only independent predictive factor for the prolonged post-surgical steroid replacement., Conclusions: Contralateral adrenal width seems to represent a significant predictive factor for the duration of post-surgical steroid replacement in subclinical Cushing syndrome patients. Pre-surgical assessment of image findings might help clinicians determine the total duration of steroid therapy after adrenalectomy., (© 2018 The Japanese Urological Association.)- Published
- 2018
- Full Text
- View/download PDF
90. Effective usage of sorghum bagasse: Optimization of organosolv pretreatment using 25% 1-butanol and subsequent nanofiltration membrane separation.
- Author
-
Teramura H, Sasaki K, Oshima T, Kawaguchi H, Ogino C, Sazuka T, and Kondo A
- Subjects
- 1-Butanol, Ethanol, Fermentation, Hydrolysis, Lignin, Cellulose, Saccharomyces cerevisiae, Sorghum
- Abstract
We investigated the use of low concentrations of butanol (<40%, all v/v) as an organosolv pretreatment to fractionate lignocellulosic biomass into cellulose, hemicellulose, and lignin. The pretreatment conditions were optimized for sorghum bagasse by focusing on four parameters: butanol concentration, sulfuric acid concentration, pretreatment temperature, and pretreatment time. A butanol concentration of 25% or higher together with 0.5% or higher acid was effective for removing lignin while retaining most of the cellulose in the solid fraction. The highest cellulose (84.9%) and low lignin (15.3%) content were obtained after pretreatment at 200 °C for 60 min. Thus, pretreatment comprising 25% butanol, 0.5% acid, 200 °C, and 60 min process time was considered optimal. Enzymatic saccharification and fermentation by Saccharomyces cerevisiae produced 61.9 g/L ethanol from 200 g/L solid fraction obtained following pretreatment, and 10.2 g/L ethanol was obtained from the liquid fraction by xylose-utilizing S. cerevisiae following membrane nanofiltration to remove butanol., (Copyright © 2017. Published by Elsevier Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
91. [A Case of Rectal Metastasis from Breast Cancer Diagnosed Two Years after Surgery].
- Author
-
Sazuka T, Miyazawa Y, Tochigi T, Hirano A, Mori M, Kosugi C, Shuto K, Kasahara K, Hiroshima Y, Matsuo K, Tanaka K, Yamazaki K, Koda K, and Matsubara H
- Subjects
- Biopsy, Needle, Breast Neoplasms drug therapy, Breast Neoplasms surgery, Fatal Outcome, Female, Humans, Middle Aged, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Breast Neoplasms pathology, Rectal Neoplasms drug therapy, Rectal Neoplasms secondary
- Abstract
We report a case of rectal metastasis from breast cancer.Colorectal metastasis from breast cancer is sometimes difficult to diagnose before surgery.A transanal needle biopsy was thought to be useful for a diagnosis and selection of treatment method.
- Published
- 2017
92. [A Comparison of the Treatment Methods for Obstructive Colorectal Cancer].
- Author
-
Isozaki T, Tasaki K, Kimura M, Fukunaga T, Sugamoto Y, Kuboshima M, Asai Y, Sazuka T, Watanabe Y, Urahama R, Kamata T, and Matsubara H
- Subjects
- Aged, Aged, 80 and over, Colectomy, Colorectal Neoplasms complications, Colorectal Neoplasms diagnosis, Humans, Intestinal Obstruction etiology, Laparoscopy, Middle Aged, Neoplasm Staging, Stents, Colorectal Neoplasms surgery, Intestinal Obstruction surgery
- Abstract
Purpose: Emergency surgery for obstructive colorectal cancer is considered to be associated with a high degree of risk, and surgery may after decompression is considered to be safer. In cases of obstructive colorectal cancer, decompression can be achieved with surgery, an ileus tube, or a stent, depending on the disease condition. We herein compare the treatment methods for obstructive colorectal cancer., Methods: Forty-two patients with obstructive colorectal cancer underwent emergency treatment between January 2012 and December 2016., Results: Among the patients with obstructive colorectal cancer, 18 receiveda stent, 10 receiveda nasal ileus tube, 6 receiveda transanal ileus tube, 5 underwent stoma construction, and 3 underwent emergency surgery without decompression. The stent group showed the highest laparoscopic operation rate. There was no significant difference in the overall survival of the treatment groups. One patient in the stent group developed duplicated cancer., Conclusion: Stent placement can be considered to be a viable option in the emergency treatment for obstructive colorectal cancer because laparoscopic surgery anda preoperative examination can be performed.
- Published
- 2017
93. Heap: a highly sensitive and accurate SNP detection tool for low-coverage high-throughput sequencing data.
- Author
-
Kobayashi M, Ohyanagi H, Takanashi H, Asano S, Kudo T, Kajiya-Kanegae H, Nagano AJ, Tainaka H, Tokunaga T, Sazuka T, Iwata H, Tsutsumi N, and Yano K
- Subjects
- Genome, Plant, Oryza genetics, Sorghum genetics, High-Throughput Nucleotide Sequencing methods, Polymorphism, Single Nucleotide, Sequence Analysis, DNA methods, Software
- Abstract
Recent availability of large-scale genomic resources enables us to conduct so called genome-wide association studies (GWAS) and genomic prediction (GP) studies, particularly with next-generation sequencing (NGS) data. The effectiveness of GWAS and GP depends on not only their mathematical models, but the quality and quantity of variants employed in the analysis. In NGS single nucleotide polymorphism (SNP) calling, conventional tools ideally require more reads for higher SNP sensitivity and accuracy. In this study, we aimed to develop a tool, Heap, that enables robustly sensitive and accurate calling of SNPs, particularly with a low coverage NGS data, which must be aligned to the reference genome sequences in advance. To reduce false positive SNPs, Heap determines genotypes and calls SNPs at each site except for sites at the both ends of reads or containing a minor allele supported by only one read. Performance comparison with existing tools showed that Heap achieved the highest F-scores with low coverage (7X) restriction-site associated DNA sequencing reads of sorghum and rice individuals. This will facilitate cost-effective GWAS and GP studies in this NGS era. Code and documentation of Heap are freely available from https://github.com/meiji-bioinf/heap (29 March 2017, date last accessed) and our web site (http://bioinf.mind.meiji.ac.jp/lab/en/tools.html (29 March 2017, date last accessed))., (© The Author 2017. Published by Oxford University Press on behalf of Kazusa DNA Research Institute.)
- Published
- 2017
- Full Text
- View/download PDF
94. Sucrose purification and repeated ethanol production from sugars remaining in sweet sorghum juice subjected to a membrane separation process.
- Author
-
Sasaki K, Tsuge Y, Kawaguchi H, Yasukawa M, Sasaki D, Sazuka T, Kamio E, Ogino C, Matsuyama H, and Kondo A
- Subjects
- Ethanol analysis, Fermentation, Glucose metabolism, Japan, Membranes, Artificial, Nanotechnology, Nitrogen metabolism, Saccharomyces cerevisiae metabolism, Sorghum chemistry, Sucrose chemistry, Ultrafiltration, Edible Grain metabolism, Ethanol metabolism, Sorghum metabolism, Sucrose isolation & purification, Sucrose metabolism
- Abstract
The juice from sweet sorghum cultivar SIL-05 (harvested at physiological maturity) was extracted, and the component sucrose and reducing sugars (such as glucose and fructose) were subjected to a membrane separation process to purify the sucrose for subsequent sugar refining and to obtain a feedstock for repeated bioethanol production. Nanofiltration (NF) of an ultrafiltration (UF) permeate using an NTR-7450 membrane (Nitto Denko Corporation, Osaka, Japan) concentrated the juice and produced a sucrose-rich fraction (143.2 g L
-1 sucrose, 8.5 g L-1 glucose, and 4.5 g L-1 fructose). In addition, the above NF permeate was concentrated using an ESNA3 NF membrane to provide concentrated permeated sugars (227.9 g L-1 ) and capture various amino acids in the juice, enabling subsequent ethanol fermentation without the addition of an exogenous nitrogen source. Sequential batch fermentation using the ESNA3 membrane concentrate provided an ethanol titer and theoretical ethanol yield of 102.5-109.5 g L-1 and 84.4-89.6%, respectively, throughout the five-cycle batch fermentation by Saccharomyces cerevisiae BY4741. Our results demonstrate that a membrane process using UF and two types of NF membranes has the potential to allow sucrose purification and repeated bioethanol production.- Published
- 2017
- Full Text
- View/download PDF
95. Differences in glucose yield of residues from among varieties of rice, wheat, and sorghum after dilute acid pretreatment.
- Author
-
Teramura H, Sasaki K, Kawaguchi H, Matsuda F, Kikuchi J, Shirai T, Sazuka T, Yamasaki M, Takumi S, Ogino C, and Kondo A
- Subjects
- Biomass, Cellulase chemistry, Fermentation, Hydrolysis, Lignin chemistry, Oryza chemistry, Sorghum chemistry, Species Specificity, Triticum chemistry, Cellulase metabolism, Glucose biosynthesis, Lignin metabolism, Sulfuric Acids chemistry
- Abstract
Bio-refinery processes require use of the most suitable lignocellulosic biomass for enzymatic saccharification and microbial fermentation. Glucose yield from biomass solid fractions obtained after dilute sulfuric acid (1%) pretreatment (at 180 °C) was investigated using 14, 8, and 16 varieties of rice, wheat, and sorghum, respectively. Biomass solid fractions of each crop showed similar cellulose content. However, glucose yield after enzymatic hydrolysis (cellulase loading at 6.6 filter paper unit/g-biomass) was different among the varieties of each crop, indicating genotypic differences for rice, wheat, and sorghum. Nuclear magnetic resonance method revealed that the high residual level of lignin aromatic regions decreased glucose yield from solid fraction of sorghum.
- Published
- 2017
- Full Text
- View/download PDF
96. Screening of rice mutants with improved saccharification efficiency results in the identification of CONSTITUTIVE PHOTOMORPHOGENIC 1 and GOLD HULL AND INTERNODE 1.
- Author
-
Hirano K, Masuda R, Takase W, Morinaka Y, Kawamura M, Takeuchi Y, Takagi H, Yaegashi H, Natsume S, Terauchi R, Kotake T, Matsushita Y, and Sazuka T
- Subjects
- Biomass, Cellulose metabolism, Coumaric Acids metabolism, Lignin metabolism, Oryza genetics, Plant Proteins genetics, Plants, Genetically Modified genetics, Plants, Genetically Modified metabolism, Oryza metabolism, Plant Proteins metabolism
- Abstract
Main Conclusion: The screening of rice mutants with improved cellulose to glucose saccharification efficiency (SE) identifies reduced xylan and/or ferulic acid, and a qualitative change of lignin to impact SE. To ensure the availability of sustainable energy, considerable effort is underway to utilize lignocellulosic plant biomass as feedstock for the production of biofuels. However, the high cost of degrading plant cell wall components to fermentable sugars (saccharification) has been problematic. One way to overcome this barrier is to develop plants possessing cell walls that are amenable to saccharification. In this study, we aimed to identify new molecular factors that influence saccharification efficiency (SE) in rice. By screening 22 rice mutants, we identified two lines, 122 and 108, with improved SE. Reduced xylan and ferulic acid within the cell wall of line 122 were probable reasons of improved SE. Line 108 showed reduced levels of thioglycolic-released lignin; however, the amount of Klason lignin was comparable to the wild-type, indicating that structural changes had occurred in the 108 lignin polymer which resulted in improved SE. Positional cloning revealed that the genes responsible for improved SE in 122 and 108 were rice CONSTITUTIVE PHOTOMORPHOGENIC 1 (OsCOP1) and GOLD HULL AND INTERNODE 1 (GH1), respectively, which have not been previously reported to influence SE. The screening of mutants for improved SE is an efficient approach to identify novel genes that affect SE, which is relevant in the development of crops as biofuel sources.
- Published
- 2017
- Full Text
- View/download PDF
97. Sorghum DW1 positively regulates brassinosteroid signaling by inhibiting the nuclear localization of BRASSINOSTEROID INSENSITIVE 2.
- Author
-
Hirano K, Kawamura M, Araki-Nakamura S, Fujimoto H, Ohmae-Shinohara K, Yamaguchi M, Fujii A, Sasaki H, Kasuga S, and Sazuka T
- Abstract
Semi-dwarf traits have been widely introgressed into cereal crops to improve lodging resistance. In sorghum (Sorghum bicolor L. Moench), four major unlinked dwarfing genes, Dw1-Dw4, have been introduced to reduce plant height, and among them, Dw3 and Dw1 have been cloned. Dw3 encodes a gene involved in auxin transport, whereas, Dw1 was recently isolated and identified as a gene encoding a protein of unknown function. In this study, we show that DW1 is a novel component of brassinosteroid (BR) signaling. Sorghum possessing the mutated allele of Dw1 (dw1), showed similar phenotypes to rice BR-deficient mutants, such as reduced lamina joint bending, attenuated skotomorphogenesis, and insensitivity against feedback regulation of BR-related genes. Furthermore, DW1 interacted with a negative regulator of BR signaling, BRASSINOSTEROID INSENSITIVE 2 (BIN2), and inhibited its nuclear localization, indicating that DW1 positively regulates BR signaling by inhibiting the function of BIN2. In contrast to rice and wheat breeding which used gibberellin (GA) deficiency to reduce plant height, sorghum breeding modified auxin and BR signaling. This difference may result from GA deficiency in rice and wheat does not cause deleterious side effects on plant morphology, whereas in sorghum it leads to abnormal culm bending.
- Published
- 2017
- Full Text
- View/download PDF
98. [KOUJIN POWDER (RED GINSENG POWDER) WITH NINJIN-YOUEITO FOR FATIGUE DUE TO TARGETED THERAPY FOR ADVANCED RENAL CELL CARCINOMA: A RETROSPECTIVE COHORT STUDY].
- Author
-
Nakamura K, Goto Y, Sazuka T, Imamura Y, Komiya A, and Ichikawa T
- Abstract
(Purpose) Targeted therapy has been standard therapeutic approach for advanced renal cell carcinoma (RCC). General fatigue is frequently observed in patients who receive targeted therapies for advanced RCC. General fatigue makes it difficult to continue a standard schedule of treatment in many cases. In this preliminary report, we explored the effect of Koujin powder (red ginseng powder) with Ninjin-youeito for general fatigue induced by targeted therapies for advanced RCC. (Material and method) The patients who complained of general fatigue during the treatment of Tyrosine Kinase Inhibitors (TKIs) as targeted therapies for advanced RCC were included in this retrospective analysis. Thirty patients with advanced RCC were enrolled from January 2016 to December 2016 at Chiba University Hospital. Twelve patients were given 3 g of Koujin powder with 9 g of Ninjin-youeito orally for two to four weeks (ginseng combination group). Eighteen patients who were not orally administered were compared as a control group (ginseng non-combination group). General fatigue was assessed with the Cancer Fatigue Scale (CFS), which divides quality of fatigue into three subgroups by using a "physical subscale", an "affective subscale", and a "cognitive subscale". We compared CFS scores at baseline and 2-8 weeks after administration. (Results) There was no statistical difference in the clinical variables between the two groups. The total CFS score was significantly decreased after treatment in the ginseng combination group (average score, 21.8 points at baseline vs 18.5 points after treatment; p=0.041). On subgroup analyses, the physical subscale score was significantly reduced after treatment in the ginseng combination group (average score, 9.7 points at baseline vs 7 points after treatment; p=0.0042). In the ginseng non-combination group, the total CFS score was significantly increased during the course (average score, 16.2 points at baseline vs 20.6 points during the course; p=0.047). On subgroup analyses, the physical subscale score was significantly increased during the course (average score, 4.4 points at baseline vs 7.3 points during the course; p=0.0042). (Conclusions) Koujin powder with Ninjin-youeito can be a therapeutic approach for general fatigue induced by targeted therapies. The precise management for general fatigue can keep patients on therapy, consequently provides a survival benefit.
- Published
- 2017
- Full Text
- View/download PDF
99. Port-site transversus abdominis fascia closure reduced the incidence of incisional hernia following retroperitoneal laparoscopic nephrectomy.
- Author
-
Takei A, Sazuka T, Nakamura K, Nihei N, and Ichikawa T
- Subjects
- Adult, Aged, Aged, 80 and over, Fascia, Female, Humans, Incidence, Incisional Hernia etiology, Incisional Hernia prevention & control, Laparoscopy adverse effects, Male, Middle Aged, Nephrectomy methods, Retroperitoneal Space surgery, Retrospective Studies, Risk Factors, Surgical Instruments adverse effects, Young Adult, Abdominal Muscles surgery, Carcinoma, Renal Cell surgery, Incisional Hernia epidemiology, Kidney Neoplasms surgery, Laparoscopy methods, Nephrectomy adverse effects
- Abstract
Purpose: The incidence of incisional hernia after laparoscopic surgery is reportedly 0-5.2 %; there are only a few reports of that following retroperitoneal laparoscopic nephrectomy. We evaluated the incidence of and risk factors for incisional hernia after retroperitoneal laparoscopic nephrectomy, and the efficacy of our novel prophylaxis technique., Methods: A total of 207 renal cell carcinoma patients who underwent laparoscopic nephrectomy at Chiba University Hospital were retrospectively enrolled in this study. We compared the incidences of incisional hernia following the transperitoneal vs. retroperitoneal approaches, and, among the latter group, the incidences with vs. without use of our prophylaxis method. Also among the retroperitoneal-approach group, we evaluated selected patient characteristics as potential hernia risk factors., Results: The rate of incisional hernias was 14 (8.7 %) after 161 retroperitoneal laparoscopic nephrectomies and one (2.2 %) after 46 transperitoneal laparoscopic nephrectomies (P = 0.132). For those undergoing the retroperitoneal approach, 14 (11.3 %) hernias were identified in 124 non-prophylaxed patients and none in 37 prophylaxed patients. Transversus abdominis fascia closure was a statistically significant factor for reducing the incidence of incisional hernia after retroperitoneal laparoscopic nephrectomy (P = 0.0324): rectus abdominis muscle thickness ≤7 mm and perioperative blood loss >100 ml were statistically significant independent risk factors, by multivariate analysis., Conclusions: To prevent incisional hernia after retroperitoneal laparoscopic nephrectomy in the patients with risk factors, it is useful to close the transversus abdominis fascia at the port sites from inside the surgical cavity, through the open specimen-removal trocar port site, under direct observation.
- Published
- 2016
- Full Text
- View/download PDF
100. Sorghum Dw1, an agronomically important gene for lodging resistance, encodes a novel protein involved in cell proliferation.
- Author
-
Yamaguchi M, Fujimoto H, Hirano K, Araki-Nakamura S, Ohmae-Shinohara K, Fujii A, Tsunashima M, Song XJ, Ito Y, Nagae R, Wu J, Mizuno H, Yonemaru J, Matsumoto T, Kitano H, Matsuoka M, Kasuga S, and Sazuka T
- Subjects
- Cell Proliferation, Chromosome Mapping, Plant Proteins metabolism, Quantitative Trait Loci, Sorghum genetics, Sorghum metabolism, Cloning, Molecular methods, Plant Proteins genetics, Sorghum growth & development
- Abstract
Semi-dwarfing genes have contributed to enhanced lodging resistance, resulting in increased crop productivity. In the history of grain sorghum breeding, the spontaneous mutation, dw1 found in Memphis in 1905, was the first widely used semi-dwarfing gene. Here, we report the identification and characterization of Dw1. We performed quantitative trait locus (QTL) analysis and cloning, and revealed that Dw1 encodes a novel uncharacterized protein. Knockdown or T-DNA insertion lines of orthologous genes in rice and Arabidopsis also showed semi-dwarfism similar to that of a nearly isogenic line (NIL) carrying dw1 (NIL-dw1) of sorghum. A histological analysis of the NIL-dw1 revealed that the longitudinal parenchymal cell lengths of the internode were almost the same between NIL-dw1 and wildtype, while the number of cells per internode was significantly reduced in NIL-dw1. NIL-dw1dw3, carrying both dw1 and dw3 (involved in auxin transport), showed a synergistic phenotype. These observations demonstrate that the dw1 reduced the cell proliferation activity in the internodes, and the synergistic effect of dw1 and dw3 contributes to improved lodging resistance and mechanical harvesting.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.